Can-Fite BioPharma (CANF) stock jumped 107% after namodenoson successfully completed Phase 2a safety testing in 20 pancreatic cancer patients.
Reported sales decreased 3.7%; organic sales increased 3.5% Introduces full-year 2026 organic sales growth, adjusted EPS and free cash flow guidance ST. PAUL, ...
Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people with this rare, devastating genetic neurodevelopmental disease- -Data support ...
Background Remission and low-disease activity are recommended targets in systemic lupus erythematosus (SLE), yet many ...
AutoCanada, Inc. engages in the operation of franchised automobile dealerships. It operates through the Canada and United States geographical segment. The firm offers a range of automotive products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results